查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1580929

芬苯達唑市場：按類型、按疾病類型、按銷售管道、按應用、按最終用戶 - 2025-2030 年全球預測

Fenbendazole Market by Type (Compound Formulations, Pure Substance), Disease Type (Cancer, Parasitic Infections), Sales Channel, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年芬苯達唑市值為8,1027萬美元，預計到2024年將達到8,7469萬美元，複合年成長率為8.11%，到2030年將達到139928萬美元。

芬苯達唑是一種廣譜驅蟲藥，主要用於獸藥，屬於苯並咪唑酮氨基甲酸酯類藥物。它廣泛用於治療動物寄生蟲感染疾病，如蛔蟲、絛蟲和其他胃腸道寄生蟲。人們強調需要芬苯達唑來有效確保牲畜、寵物和其他動物的健康和生產力。該產品可以在獸醫醫院、畜牧業和農業經營中得到重要應用，在這些領域，維持牲畜的健康對於經濟生存至關重要。它在人類中的應用也已出現，儘管有限，但有軼事證據和研究探索潛在的抗癌作用。

主要市場統計
基準年[2023] 81027萬美元
預測年份 [2024] 87469萬美元
預測年份 [2030] 1,399.28 百萬美元
複合年成長率（%） 8.11%

芬苯達唑市場受到全球動物健康意識增強、寄生蟲感染增加、獸醫技術進步以及肉類和乳製品需求增加等因素的影響。人類製劑存在潛在的商機，但這需要大量的研究和監管導航。藥物輸送系統的創新也推動了成長，以提高功效和動物依從性。然而，市場擴張受到嚴格的法規環境、潛在副作用、替代抗寄生蟲藥物的競爭以及有關人類仿單標示外使用的倫理爭論的限制。

強勁的研發投資帶來了配方創新，並提高了生物有效性和治療效率。目前的研究使我們能夠探索效用，並研究已報導的人類可能的抗癌作用。市場競爭激烈，新的機會需要透過提高功效、安全性和成本效益來實現差異化。促進製藥公司和研究機構之間的合作以確保遵守監管標準非常重要。應對這些挑戰，同時加速探索新應用並推廣其效益，將確保芬苯達唑的持續市場相關性和成長潛力。

市場動態：揭示快速發展的芬苯達唑市場的關鍵市場洞察

芬苯達唑市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加芬苯達唑在動物保健領域的核准和使用的監管支持政策
    • 全球寵物擁有率上升刺激了對廣譜驅蟲劑的需求
    • 集中畜牧業推動了對有效寄生蟲控制解決方案的需求
  • 市場限制因素
    • 開發適合不同動物物種的芬苯達唑製劑的成本限制
  • 市場機會
    • 透過開發芬苯達唑聯合療法實現更全面的動物健康
    • 在野生動物管理計劃中引入芬苯達唑以控制寄生蟲傳播
  • 市場挑戰
    • 關於芬苯達唑對農業生態系殘留影響的環境問題

波特的五力：駕馭芬苯達唑市場的策略工具

波特的五力架構是了解芬苯達唑市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解芬苯達唑市場的外部影響

外部宏觀環境因素對芬苯達唑市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解芬苯達唑市場的競爭格局

對芬苯達唑市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣芬苯達唑市場供應商的績效評估

FPNV定位矩陣是評估芬苯達唑市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了芬苯達唑市場的成功之路

芬苯達唑市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 加強監管政策支持芬苯達唑在動物保健領域的核准和使用
      • 全球寵物擁有率不斷上升刺激了廣譜驅蟲藥的需求
      • 集中畜牧業增加了對有效寄生蟲控制解決方案的需求
    • 抑制因素
      • 開發適合不同物種的芬苯達唑製劑的成本限制
    • 機會
      • 開發包括芬苯達唑在內的聯合治療方法，以涵蓋更全面的動物健康
      • 將芬苯達唑引入野生動物管理計畫以控制寄生蟲傳播
    • 任務
      • 關於芬苯達唑對農業生態系殘留影響的環境問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章芬苯達唑市場：依類型

  • 複雜的準備工作
    • 粉末
    • 暫停
    • 藥片
  • 純物質

第7章芬苯達唑市場：依疾病類型

  • 癌症
    • 乳癌
    • 肺癌
    • 攝護腺癌
  • 寄生蟲感染疾病
    • 胃腸道寄生蟲
    • 肺線蟲

第8章芬苯達唑市場：依銷售管道

  • 直銷
  • 經銷商
  • 網路藥房
  • 零售藥房

第9章芬苯達唑市場：依應用分類

  • 製藥
    • 動物用藥品
    • 人類醫學
  • 獸醫學
    • 伴同性動物
      • 貓
      • 狗
    • 馬
    • 家畜
      • 牛
      • 豬
      • 羊

第 10 章 芬苯達唑市場：依最終使用者分類

  • 動物農場
  • 製藥公司
  • 調查機構
  • 獸醫診所

第11章 芬苯達唑美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區芬苯達唑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲芬苯達唑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • FDA核准Safeguard 用於治療野生鵪鶉胃腸道寄生蟲
    • 默克以13億美元收購Elanco的Aqua業務
    • Ceva 收購 Scout Bio 擴大生物製藥業務
  • 戰略分析和建議
    • 默克公司

公司名單

  • ADM Animal Nutrition
  • Alltech, Inc.
  • Blue Buffalo Pet Products, Inc.
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Cipla Limited
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Huvepharma by Olon Spa
  • Kemin Industries, Inc.
  • Krka, dd, Novo mesto
  • Lasa Supergenerics Ltd.
  • Leo Bio-Care Pvt. Ltd.
  • Merck & Co., Inc.
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-1A1A064BFFCB

The Fenbendazole Market was valued at USD 810.27 million in 2023, expected to reach USD 874.69 million in 2024, and is projected to grow at a CAGR of 8.11%, to USD 1,399.28 million by 2030.

Fenbendazole, a broad-spectrum anthelmintic medication primarily used in veterinary medicine, falls under the class of benzimidazole carbamate drugs. It is extensively applied for managing parasitic infestations like roundworms, tapeworms, and other gastrointestinal parasites in animals. The necessity for fenbendazole is underscored by its efficacy in ensuring the health and productivity of livestock, pets, and other animals. The product finds significant application in veterinary clinics, animal husbandry, and farming operations where maintaining the health of livestock is paramount for economic viability. Human usage has also surfaced, although limited and often debated, in context with anecdotal evidence and research exploring potential anti-cancer properties.

KEY MARKET STATISTICS
Base Year [2023] USD 810.27 million
Estimated Year [2024] USD 874.69 million
Forecast Year [2030] USD 1,399.28 million
CAGR (%) 8.11%

The market for fenbendazole is influenced by factors such as increasing global awareness about animal health, rising incidences of parasitic infections, advancements in veterinary medicine, and heightened demand for meat and dairy products. There is a potential opportunity in human health formulations, but this requires substantial research and regulatory navigation. Growth is also driven by innovations in drug delivery systems for enhanced efficacy and animal compliance. However, market expansion is constrained by stringent regulatory environments, potential side effects, competition from alternative antiparasitic drugs, and ethical debates regarding off-label human use.

Investment in robust R&D can lead to innovations in fenbendazole formulations that enhance bioavailability and therapeutic efficiency. Current research could explore its utility in more precise treatments for specific parasitic species and investigate its reported anti-cancer potential in humans. The market exhibits a competitive landscape requiring differentiation through enhanced efficacy, safety profiles, and cost-effectiveness to capitalize on emerging opportunities. Promoting collaboration among pharmaceutical companies and research institutions, along with ensuring compliance with regulatory standards, is crucial. Addressing these challenges while expediting research on novel applications and extolling the benefits ensures sustained market relevance and growth potential for fenbendazole.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fenbendazole Market

The Fenbendazole Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing supportive regulatory policies for the approval and usage of fenbendazole in animal healthcare
    • Rising pet ownership rates globally stimulating the demand for broad-spectrum anthelmintics
    • Intensive livestock farming practices raising the necessity for effective parasitic control solutions
  • Market Restraints
    • Cost constraints in developing fenbendazole formulations suited for diverse species
  • Market Opportunities
    • Developing combination treatments involving fenbendazole for more comprehensive animal health coverage
    • Introduction of fenbendazole in wildlife management programs to control parasite infestations
  • Market Challenges
    • Environmental concerns surrounding fenbendazole's residual impact in agricultural ecosystems

Porter's Five Forces: A Strategic Tool for Navigating the Fenbendazole Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fenbendazole Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fenbendazole Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fenbendazole Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fenbendazole Market

A detailed market share analysis in the Fenbendazole Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fenbendazole Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fenbendazole Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fenbendazole Market

A strategic analysis of the Fenbendazole Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fenbendazole Market, highlighting leading vendors and their innovative profiles. These include ADM Animal Nutrition, Alltech, Inc., Blue Buffalo Pet Products, Inc., Boehringer Ingelheim Animal Health, Ceva Sante Animale, Cipla Limited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Huvepharma by Olon S.p.a., Kemin Industries, Inc., Krka, d. d., Novo mesto, Lasa Supergenerics Ltd., Leo Bio-Care Pvt. Ltd., Merck & Co., Inc., Nutreco N.V., Phibro Animal Health Corporation, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Fenbendazole Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Compound Formulations and Pure Substance. The Compound Formulations is further studied across Powder, Suspension, and Tablets.
  • Based on Disease Type, market is studied across Cancer and Parasitic Infections. The Cancer is further studied across Breast Cancer, Lung Cancer, and Prostate Cancer. The Parasitic Infections is further studied across Gastrointestinal Parasites and Lungworms.
  • Based on Sales Channel, market is studied across Direct Sales, Distributors, Online Pharmacies, and Retail Pharmacies.
  • Based on Application, market is studied across Pharmaceutical and Veterinary Medicine. The Pharmaceutical is further studied across Animal Medicines and Human Medicines. The Veterinary Medicine is further studied across Companion Animals, Equine, and Livestock Animals. The Companion Animals is further studied across Cats and Dogs. The Livestock Animals is further studied across Cattle, Pigs, and Sheep.
  • Based on End User, market is studied across Animal Farms, Pharmaceutical Companies, Research Institutions, and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing supportive regulatory policies for the approval and usage of fenbendazole in animal healthcare
      • 5.1.1.2. Rising pet ownership rates globally stimulating the demand for broad-spectrum anthelmintics
      • 5.1.1.3. Intensive livestock farming practices raising the necessity for effective parasitic control solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Cost constraints in developing fenbendazole formulations suited for diverse species
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing combination treatments involving fenbendazole for more comprehensive animal health coverage
      • 5.1.3.2. Introduction of fenbendazole in wildlife management programs to control parasite infestations
    • 5.1.4. Challenges
      • 5.1.4.1. Environmental concerns surrounding fenbendazole's residual impact in agricultural ecosystems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fenbendazole Market, by Type

  • 6.1. Introduction
  • 6.2. Compound Formulations
    • 6.2.1. Powder
    • 6.2.2. Suspension
    • 6.2.3. Tablets
  • 6.3. Pure Substance

7. Fenbendazole Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Cancer
    • 7.2.1. Breast Cancer
    • 7.2.2. Lung Cancer
    • 7.2.3. Prostate Cancer
  • 7.3. Parasitic Infections
    • 7.3.1. Gastrointestinal Parasites
    • 7.3.2. Lungworms

8. Fenbendazole Market, by Sales Channel

  • 8.1. Introduction
  • 8.2. Direct Sales
  • 8.3. Distributors
  • 8.4. Online Pharmacies
  • 8.5. Retail Pharmacies

9. Fenbendazole Market, by Application

  • 9.1. Introduction
  • 9.2. Pharmaceutical
    • 9.2.1. Animal Medicines
    • 9.2.2. Human Medicines
  • 9.3. Veterinary Medicine
    • 9.3.1. Companion Animals
      • 9.3.1.1. Cats
      • 9.3.1.2. Dogs
    • 9.3.2. Equine
    • 9.3.3. Livestock Animals
      • 9.3.3.1. Cattle
      • 9.3.3.2. Pigs
      • 9.3.3.3. Sheep

10. Fenbendazole Market, by End User

  • 10.1. Introduction
  • 10.2. Animal Farms
  • 10.3. Pharmaceutical Companies
  • 10.4. Research Institutions
  • 10.5. Veterinary Clinics

11. Americas Fenbendazole Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Fenbendazole Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Fenbendazole Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. FDA approves Safe-Guard for treatment of GI worms in wild quail
    • 14.3.2. Merck acquires Elanco's Aqua business for USD 1.3 billion
    • 14.3.3. Ceva acquires Scout Bio to expand biotherapeutic initiatives
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Merck & Co., Inc.

Companies Mentioned

  • 1. ADM Animal Nutrition
  • 2. Alltech, Inc.
  • 3. Blue Buffalo Pet Products, Inc.
  • 4. Boehringer Ingelheim Animal Health
  • 5. Ceva Sante Animale
  • 6. Cipla Limited
  • 7. Dechra Pharmaceuticals PLC
  • 8. Elanco Animal Health Incorporated
  • 9. Evonik Industries AG
  • 10. Huvepharma by Olon S.p.a.
  • 11. Kemin Industries, Inc.
  • 12. Krka, d. d., Novo mesto
  • 13. Lasa Supergenerics Ltd.
  • 14. Leo Bio-Care Pvt. Ltd.
  • 15. Merck & Co., Inc.
  • 16. Nutreco N.V.
  • 17. Phibro Animal Health Corporation
  • 18. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • 19. Vetoquinol S.A.
  • 20. Virbac S.A.
  • 21. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. FENBENDAZOLE MARKET RESEARCH PROCESS
  • FIGURE 2. FENBENDAZOLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FENBENDAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FENBENDAZOLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. FENBENDAZOLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. FENBENDAZOLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FENBENDAZOLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FENBENDAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FENBENDAZOLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FENBENDAZOLE MARKET DYNAMICS
  • TABLE 7. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FENBENDAZOLE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FENBENDAZOLE MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FENBENDAZOLE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FENBENDAZOLE MARKET SIZE, BY PURE SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FENBENDAZOLE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FENBENDAZOLE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FENBENDAZOLE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FENBENDAZOLE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FENBENDAZOLE MARKET SIZE, BY GASTROINTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FENBENDAZOLE MARKET SIZE, BY LUNGWORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FENBENDAZOLE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FENBENDAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL FENBENDAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL FENBENDAZOLE MARKET SIZE, BY ANIMAL MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL FENBENDAZOLE MARKET SIZE, BY HUMAN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL FENBENDAZOLE MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL FENBENDAZOLE MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL FENBENDAZOLE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL FENBENDAZOLE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL FENBENDAZOLE MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL FENBENDAZOLE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL FENBENDAZOLE MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL FENBENDAZOLE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 295. DENMARK FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. DENMARK FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. EGYPT FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. EGYPT FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 317. EGYPT FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 318. EGYPT FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. FINLAND FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. FINLAND FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 324. FINLAND FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. FINLAND FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 327. FINLAND FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 328. FINLAND FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 329. FINLAND FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 330. FINLAND FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 331. FRANCE FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. FRANCE FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 333. FRANCE FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. FRANCE FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 335. FRANCE FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 336. FRANCE FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. FRANCE FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 339. FRANCE FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 340. FRANCE FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 341. FRANCE FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 342. FRANCE FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 343. GERMANY FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. GERMANY FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 345. GERMANY FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 346. GERMANY FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 347. GERMANY FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 348. GERMANY FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 349. GERMANY FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 350. GERMANY FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 351. GERMANY FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 352. GERMANY FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 353. GERMANY FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 354. GERMANY FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 355. ISRAEL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. ISRAEL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 357. ISRAEL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. ISRAEL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 359. ISRAEL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 360. ISRAEL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 361. ISRAEL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 362. ISRAEL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 363. ISRAEL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
  • TABLE 364. ISRAEL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 365. ISRAEL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 366. ISRAEL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 367. ITALY FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 368. ITALY FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 369. ITALY FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION